History and progress of hypotheses and clinical trials for Alzheimer's disease
PP Liu, Y Xie, XY Meng, JS Kang - Signal transduction and targeted …, 2019 - nature.com
Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive
memory loss along with neuropsychiatric symptoms and a decline in activities of daily life. Its …
memory loss along with neuropsychiatric symptoms and a decline in activities of daily life. Its …
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
BV Zlokovic - Nature Reviews Neuroscience, 2011 - nature.com
The neurovascular unit (NVU) comprises brain endothelial cells, pericytes or vascular
smooth muscle cells, glia and neurons. The NVU controls blood–brain barrier (BBB) …
smooth muscle cells, glia and neurons. The NVU controls blood–brain barrier (BBB) …
Glucose transporters at the blood-brain barrier: function, regulation and gateways for drug delivery
SG Patching - Molecular neurobiology, 2017 - Springer
Glucose transporters (GLUTs) at the blood-brain barrier maintain the continuous high
glucose and energy demands of the brain. They also act as therapeutic targets and provide …
glucose and energy demands of the brain. They also act as therapeutic targets and provide …
Physical exercise as a preventive or disease-modifying treatment of dementia and brain aging
JE Ahlskog, YE Geda, NR Graff-Radford… - Mayo clinic …, 2011 - Elsevier
A rapidly growing literature strongly suggests that exercise, specifically aerobic exercise,
may attenuate cognitive impairment and reduce dementia risk. We used PubMed (keywords …
may attenuate cognitive impairment and reduce dementia risk. We used PubMed (keywords …
Deficiency in Mural Vascular Cells Coincides with Blood–Brain Barrier Disruption in A lzheimer's Disease
JD Sengillo, EA Winkler, CT Walker… - Brain …, 2013 - Wiley Online Library
Neurovascular dysfunction contributes to A lzheimer's disease (AD). Cerebrovascular
abnormalities and blood–brain barrier (BBB) damage have been shown in AD. The BBB …
abnormalities and blood–brain barrier (BBB) damage have been shown in AD. The BBB …
Cognitive frailty, a novel target for the prevention of elderly dependency
Q Ruan, Z Yu, M Chen, Z Bao, J Li, W He - Ageing research reviews, 2015 - Elsevier
Frailty is a complex and heterogeneous clinical syndrome. Cognitive frailty has been
considered as a subtype of frailty. In this study, we refine the definition of cognitive frailty …
considered as a subtype of frailty. In this study, we refine the definition of cognitive frailty …
Early adult to midlife cardiovascular risk factors and cognitive function
K Yaffe, E Vittinghoff, MJ Pletcher, TD Hoang… - Circulation, 2014 - Am Heart Assoc
Background—Studies have linked midlife and late-life cardiovascular risk factors (CVRFs) to
cognitive function, yet little is known about CVRF exposure in early adulthood and …
cognitive function, yet little is known about CVRF exposure in early adulthood and …
Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin
To determine incidence of dementia in type 2 diabetic (T2DM) patients, and whether there
are adverse or favorable effects of oral agents (OA) in DM, we obtained a representative …
are adverse or favorable effects of oral agents (OA) in DM, we obtained a representative …
Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease
P Grammas - Journal of neuroinflammation, 2011 - Springer
Alzheimer's disease (AD) is an age-related disorder characterized by progressive cognitive
decline and dementia. Alzheimer's disease is an increasingly prevalent disease with 5.3 …
decline and dementia. Alzheimer's disease is an increasingly prevalent disease with 5.3 …
The utility of cerebral blood flow as a biomarker of preclinical Alzheimer's disease
There is accumulating evidence suggesting that changes in brain perfusion are present long
before the clinical symptoms of Alzheimer's disease (AD), perhaps even before amyloid-β …
before the clinical symptoms of Alzheimer's disease (AD), perhaps even before amyloid-β …